rs11896293
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001378454.1(ALMS1):c.11054G>A(p.Ser3685Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00408 in 1,613,996 control chromosomes in the GnomAD database, including 231 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001378454.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0212 AC: 3219AN: 152044Hom.: 106 Cov.: 32
GnomAD3 exomes AF: 0.00536 AC: 1335AN: 249220Hom.: 39 AF XY: 0.00419 AC XY: 567AN XY: 135318
GnomAD4 exome AF: 0.00230 AC: 3358AN: 1461834Hom.: 124 Cov.: 32 AF XY: 0.00205 AC XY: 1489AN XY: 727216
GnomAD4 genome AF: 0.0212 AC: 3227AN: 152162Hom.: 107 Cov.: 32 AF XY: 0.0203 AC XY: 1512AN XY: 74394
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
- -
Alstrom syndrome Benign:4
- -
Potent mutations in ALMS1 are associated with a rare condition called Alstrom syndrome. It can cause excessive eating, insulin resistance. However, no evidence is found to ascertain the role of rs11896293 in Alstrom syndrome yet. -
- -
- -
not specified Benign:3
- -
p.Ser3684Asn in exon 16 of ALMS1: This variant is not expected to have clinical significance because it has been identified in 7.58% (734/9688) of African chrom osomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org ; dbSNP rs11896293). -
This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Monogenic diabetes Benign:1
ACMG criteria: BP4 (REVEL score 0.034 + 8 predictors), BA1 (7.4% in gnomAD African) , BS2(70 homozygotes in gnomAD), BP1 (missense when truncating causes disease)= benign -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at